Skip to content

iCBT for Adolescents With Co-morbid Insomnia

Internet-delivered Cognitive Behaviour Therapy for Adolescents With Co-morbid Insomnia Attending Children and Youth Psychiatry: An Open Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02612987
Enrollment
21
Registered
2015-11-24
Start date
2015-10-31
Completion date
2017-10-31
Last updated
2018-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyssomnias

Keywords

CBT, Internet based

Brief summary

Insomnia is a commonly reported comorbidity for adolescents with psychiatric conditions. It is well-known that insomnia can exacerbate the concurrent psychiatric symptom load. Treatment of insomnia has been extensively examined in adults, but studies with adolescents are sparse. The purpose of this pilot study is to assess the feasibility and efficacy of internet-based cognitive behavioral therapy for insomnia (iCBT) in outpatients of Children and Youth Psychiatry. Twenty-one adolescents will be recruited and receive 7 weeks of iCBT. Outcome will be measured at pre treatment, at post treatment and at a three months follow-up. Weekly assessments will also be made during treatment on primary outcome and a presumed process variable constructed for the purpose of this trial.

Interventions

Sponsors

Karolinska Institutet
CollaboratorOTHER
Uppsala University
CollaboratorOTHER
Uppsala University Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
13 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* To fulfill the diagnostic criteria for insomnia * To have access to a computer with Internet connection * No previous or ongoing CBT for insomnia * No psychotropic medication or being on a stable dosage for at least six weeks before enrollment

Exclusion criteria

* Ongoing manic or psychotic episode * Being at high risk of triggering manic or psychotic episode * Ongoing sleep apnea

Design outcomes

Primary

MeasureTime frameDescription
Insomnia Severity Index (ISI; Morin, 1993)Pre treatment, weekly during treatment (e.g. from date of treatment start for seven weeks until treatment is terminated), post treatment (e.g. seven weeks after the patient has started treatment), 3 month follow-upGiven that this is an intervention study we are assessing changes in outcome over time.

Secondary

MeasureTime frameDescription
The Core Consensus Sleep Diary (Core CSD; Carney et al., 2012)Pre treatment, weekly during treatment (e.g. from date of treatment start for seven weeks until treatment is terminated), post treatment (e.g. seven weeks after the patient has started treatment), 3 month follow-upGiven that this is an intervention study we are assessing changes in outcome over time.
Symptoms Checklist (SCL-90; Derogatis et al., 1994)Pre treatment, post treatment (e.g. seven weeks after the patient has started treatment), 3 month follow-upGiven that this is an intervention study we are assessing changes in outcome over time.
Montgomery-Åsberg Depression Rating Scale - Self report (MADRS-S; Svanborg & Åsberg, 1994)Pre treatment, post treatment (e.g. seven weeks after the patient has started treatment), 3 month follow-upGiven that this is an intervention study we are assessing changes in outcome over time.

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026